Cost-effectiveness of digital therapeutics for essential hypertension

Hypertension increases the risk of cardiovascular and other diseases. Lifestyle modification is a significant component of nonpharmacological treatments for hypertension. We previously reported the clinical efficacy of digital therapeutics (DTx) in the HERB-DH1 trial. However, there is still a lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomura, Akihiro, Tanigawa, Tomoyuki, Kario, Kazuomi, Igarashi, Ataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474296/
https://www.ncbi.nlm.nih.gov/pubmed/35726085
http://dx.doi.org/10.1038/s41440-022-00952-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474296/
https://www.ncbi.nlm.nih.gov/pubmed/35726085
http://dx.doi.org/10.1038/s41440-022-00952-x

Ejemplares similares